Company
The Great Pioneer for Incurable Diseasest

리스큐어바이오사이언시스는 글로벌 임상단계의 혁신신약 연구개발 전문기업으로 미생물 기반 면역항암 주사제와 경구형 마이크로바이옴 치료제를 개발하고 있습니다.

Leadership
Team
  • CEO
    진화섭
    Bio Industry 20+ yrs
  • COO
    심재석, Ph.D.
    Material development,
    Industrialization 20+ yrs
  • CFO
    길준영, CPA
    Investment 12+ yrs
  • CTO
    노성운, Ph.D.
    Microbiome research 20+ yrs
  • CTO
    송경섭, Ph.D.
    Metabolism research 14+ yrs
Scientific Advisory Board
  • SAB
    Theresa LaVallee, Ph.D.
    Pre-clinical, clinical 25+ yrs
  • SAB
    Robert R. Jenq, M.D.
    Cancer immunology 20+ yrs
  • SAB
    Nicholas F. LaRusso, M.D.
    Liver disease 35+ yrs
R&D Advisory
  • David J. Pepperl, Ph.D.
    Pre-clinical, IND 20+ yrs
  • 김철, M.D., Ph.D.
    Clinical medicine, Oncology 25+ yrs
  • 남기연, Ph.D.
    Clinical development 20+ yrs
  • 강윤구, MD., Ph.D.
    Clinical Medicine, Oncology 30+yrs
Co-Researchers
  • Harmeet Malhi, M.B.B.S.
    Mayo Clinic,
    Liver disease 20+ yrs
  • Howard C. Hang, Ph. D.
    Scripps Research Institute,
    Bacteria Immunology 20+ yrs